Yokohama City  2025 Trial Grant Selected．

06/05/2025 Last updated : 07/19/2025 manager

Our research will focus on cancer stem cell organoid culture for the development of cancer immunotherapy cell medicine.

Categories
News
Previous article
We will be exhibiting at the BioJapan 2025 exhibition in October.
06/01/2025
Next article
Moved into Shonan iPark and started R&D activities.
07/01/2025